Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry - Meral Günes, Adalet; Millot, Frédéric; Kalwak, Krzysztof; Lausen, Birgitte; Sedlacek, Petr; Versluys, A. Birgitta; Dworzak, Michael; De Moerloose, Barbara; Suttorp, Meinolf (Pediatric Blood & Cancer, 2021)
Keywords: Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Child, Preschool; children; Combined Modality Therapy; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cell Transplantation - mortality; Humans; imatinib; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy; Male; pediatric CML; Prognosis; Registries; Registries - statistics & numerical data; side effects; Survival Rate; very young age; imatinib; side effects; pediatric CML; children; very young age